Onivyde pancreatic cancer：Onivyde® regimen demonstrated statistically ...
Onivyde® regimen demonstrated statistically ...
2022年11月9日—Onivyde®regimendemonstratedstatisticallysignificantimprovementinoverallsurvivalinpreviouslyuntreatedmetastaticpancreaticductal ...。其他文章還包含有：「MetastaticPancreaticCancerTreatmentwithONIVYDE®...」、「Onivyde®improvessurvivalinPhaseIIIpancreaticcancer...」、「LiposomalIrinotecan」、「Ipsen'sOnivydeturnsinpositiveresultsinpancreaticcancer」、「Onivydepegylatedliposomal(prev...
查看更多 離開網站
Metastatic Pancreatic Cancer Treatment with ONIVYDE® ...
https://www.onivyde.com
ONIVYDE is a prescription medicine used to treat pancreatic cancer which has spread to other parts of the body. ONIVYDE can be used in patients who have ...
Onivyde® improves survival in Phase III pancreatic cancer ...
https://www.europeanpharmaceut
Onivyde® (irinotecan liposome injection) treatment regimen significantly improved survival in a Phase III trial compared to nab-paclitaxel ...
Liposomal Irinotecan
https://www.ncbi.nlm.nih.gov
Liposomal irinotecan (nal-IRI; Onivyde®; also known as pegylated liposomal irinotecan) has been developed with the aim of maximising ...
Ipsen's Onivyde turns in positive results in pancreatic cancer
https://www.fiercepharma.com
Ipsen's Onivyde proved its worth in previously untreated pancreatic ductal adenocarcinoma, a notoriously tough to treat cancer type.
Onivyde pegylated liposomal (previously known as Onivyde)
https://www.ema.europa.eu
Onivyde pegylated liposomal is a cancer medicine that is used to treat a form of pancreatic cancer called metastatic adenocarcinoma of the pancreas.